NewsFeed Voices Science Insight Innovation
January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Maartje van den Biggelaar: LSBR Awarded Our Consortium the LSBR Anniversary Grant of €1.6 Million to Launch HemoTwin-BD
Maartje van den Biggelaar/LinkedIn
Dec 1, 2025, 15:25

Maartje van den Biggelaar: LSBR Awarded Our Consortium the LSBR Anniversary Grant of €1.6 Million to Launch HemoTwin-BD

Maartje van den Biggelaar, Head of laboratory of Proteomics at Sanquin, shared a post on LinkedIn:

“Proteomics of hemostasis

Extremely proud and happy that The Landsteiner Foundation for Blood Transfusion Research (LSBR) awarded our consortium the LSBR Anniversary Grant of €1.6 million to launch HemoTwin-BD, a multidisciplinary program to unravel why patients with inherited bleeding disorders or an unexplained bleeding tendency can have very different bleeding phenotypes.

This grant gives us the opportunity to combine large national patient studies and scientific expertise to investigate how genetic variationtranslates into proteoforms that shape the hemostatic potential. Using AI-based modelling we will build digital twins to uncover new biological mechanisms and ultimately pave the way for more personalized and safer treatment strategies.

A big thank you to all consortium partners—from clinical experts and fundamental researchers to data scientists—and to The Landsteiner Foundation for Blood Transfusion Research (LSBR) for their trust in our work.”

Maartje van den Biggelaar: LSBR Awarded Our Consortium the LSBR Anniversary Grant of €1.6 Million to Launch HemoTwin-BD

Stay updated with Hemostasis Today.

AI-based modelling Health Hematology Hemostasis Hemostasis Today HemoTwin-BD Inherited bleeding disorders Maartje van den Biggelaar Medicine The Landsteiner Foundation for Blood Transfusion Research (LSBR)
NewsFeed